Entering text into the input field will update the search result below

Albireo Pharma GAAP EPS of -$0.57, revenue of $32.52M

Mar. 01, 2022 8:41 AM ETAlbireo Pharma, Inc. (ALBO) StockBy: Deepa Sarvaiya, SA News Editor
  • Albireo Pharma press release (NASDAQ:ALBO): Q4 GAAP EPS of -$0.57.
  • Revenue of $32.52M (vs $2.72M in Q420).

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

Related Stocks

SymbolLast Price% Chg
Albireo Pharma, Inc.
Mirum Pharmaceuticals, Inc.
Ipsen S.A.
Addex Therapeutics Ltd
Chemomab Therapeutics Ltd.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.